Research & Development World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars

Scientists identify major source of cells’ defense against oxidative stress

By R&D Editors | April 9, 2012

Both radiation and many forms of chemotherapy try to kill tumors by causing
oxidative stress in cancer cells. New research from the University of Southern California
(USC) on a protein that protects cancer and other cells from these stresses
could one day help doctors to break down cancer cells’ defenses, making them
more susceptible to treatment.

In The Journal of Biological Chemistry, scientists led by USC
professor Kelvin J. A. Davies demonstrated that a protein known as Nrf2 governs
a cell’s ability to cope with oxidative stress by increasing the expression of
key genes for removing damaged proteins.

Typically, oxidative stress is to be avoided. People eat foods high in
antioxidants, such as fruits and vegetables, to try to block oxidation in their
cells, in hopes of lowering their risk of illnesses, such as cancer, heart
disease, stroke, and Alzheimer’s disease—which all are linked to oxidative
stress.

But in the case of cancer cells, if the Nrf2 response some day could be
selectively turned off, treatments like chemotherapy and radiation could be
more effective, Davies said.

“One of the problems you have is that cancer cells start becoming resistant
to those treatments—they adapt,” said Davies, who holds appointments at the USC
Davis School of Gerontology the USC Dornsife College of Letters, Arts, and
Sciences. “The next time they may be more resistant because they’ve seen it
before.”

Nrf2 is a transcription factor protein, meaning that it binds to specific
sequences of DNA, turning on the process of copying the blueprints encoded in
those DNA sequences into functional enzymes.

In particular, the new work from the Davies laboratory shows that production
of proteasome and a proteasome regulator (Pa28) is controlled by Nrf2 during
oxidative stress. Proteosome, in turn, is a large protein enzyme that breaks
down oxidized proteins that otherwise would accumulate and cause cells to die.

When oxidative stress increases (which can be simulated in the lab by adding
hydrogen peroxide—the major product of both radiation therapy and chemotherapy),
Davies and his team found that the Nrf2 in a cell starts ramping up proteasome
production.

The researchers then tested their findings by blocking Nrf2 with various
chemical and genetic inhibitors, which decreased the cell’s ability to make
more proteasome and cope with the hydrogen peroxide.

In normal young cells, Nrf2 allows continuous regulation of proteasome
production in response to changing oxidative environments. This ability may
decline in aging and age-related diseases, making older individuals less able
to cope with stress.

“We would like to be able to reverse this decline in normal cells while
making cancer cells less stress-resistant and more easily killed by radiation
therapy and chemotherapy,” Davies said.

University of Southern California

Related Articles Read More >

Novel mass spectrometry solution simplifies insight gathering into macromolecular complexes
ENPICOM launches display solution to accelerate antibody selection while maximizing precision
Thermo Fisher Scientific autoimmune-testing instruments now available in the U.S.
Thermo Fisher Scientific and Qatar Genome Program partner to advance precision medicine 
2021 R&D Global Funding Forecast

Need R&D World news in a minute?

We Deliver!
R&D World Enewsletters get you caught up on all the mission critical news you need in research and development. Sign up today.
Enews Signup

R&D World Digital Issues

February 2020 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R& magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • 2021 Global Funding Forecast

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars